Beneficial effects of ethyl pyruvate in septic shock from peritonitis.

HYPOTHESIS Infusion of ethyl pyruvate (EP) solution can improve outcome in a clinically relevant, large- animal model of septic shock resulting from fecal peritonitis. DESIGN Prospective randomized animal study. SETTING University hospital animal research laboratory. SUBJECTS Fourteen female sheep. INTERVENTIONS Fourteen fasted, anesthetized, invasively monitored, mechanically ventilated female sheep weighing (mean +/- SD) 30.4 +/- 3.8 kg received 0.5 g/kg of feces intraperitoneally to induce peritonitis, without administration of antibiotic agents or vasoactive drugs. After surgical preparation, the ewes were randomized to receive a continuous intravenous infusion at 15 mg/kg per hour of either EP combined with Ringer lactate solution or Ringer lactate solution only. Fluid resuscitation was titrated to maintain the pulmonary artery occlusion pressure at baseline levels throughout the experiment. All animals were monitored until they died spontaneously or for a maximum of 30 hours. RESULTS Compared with Ringer lactate solution alone, EP administration resulted in less tachycardia, longer time to development of arterial hypotension and oliguria (median, 27 vs 15 hours and 24 vs 16 hours, respectively; both P<.01), and prolonged survival time (median, 29.5 vs 17.0 hours; P<.001). Animals who received EP also had a smaller decrease in colloid osmotic pressure (P<.05) and a tendency for lower serum interleukin 6 concentrations (P = .08). CONCLUSIONS In this clinically relevant model of septic shock in ewes, continuous EP infusion prolonged time to development of organ dysfunction and markedly prolonged survival. These findings suggest a potential use for EP in the treatment of severe sepsis and septic shock.

[1]  C. Sprung,et al.  Sepsis in European intensive care units: Results of the SOAP study* , 2006, Critical care medicine.

[2]  P. Asfar,et al.  Ethyl pyruvate improves systemic and hepatosplanchnic hemodynamics and prevents lipid peroxidation in a porcine model of resuscitated hyperdynamic endotoxemia* , 2005, Critical care medicine.

[3]  F. Lin,et al.  Future strategies in the treatment of acute renal failure: growth factors, stem cells, and other novel therapies , 2005, Current opinion in pediatrics.

[4]  M. Fink,et al.  Ethyl Pyruvate Inhibits Nuclear Factor-κB-Dependent Signaling by Directly Targeting p65 , 2004, Journal of Pharmacology and Experimental Therapeutics.

[5]  M. Fink,et al.  ETHYL PYRUVATE REDUCES LIVER INJURY IN A MURINE MODEL OF EXTRAHEPATIC CHOLESTASIS , 2004, Shock.

[6]  J. Vincent,et al.  USE OF LOW TIDAL VOLUME IN SEPTIC SHOCK MAY DECREASE SEVERITY OF SUBSEQUENT ACUTE LUNG INJURY , 2004, Shock.

[7]  M. Fink,et al.  Ethyl pyruvate ameliorates distant organ injury in a murine model of acute necrotizing pancreatitis* , 2004, Critical care medicine.

[8]  G. Lopaschuk,et al.  Pyruvate prevents cardiac dysfunction and AMP-activated protein kinase activation by hydrogen peroxide in isolated rat hearts. , 2004, Canadian journal of physiology and pharmacology.

[9]  M. Berry,et al.  Ethyl pyruvate preserves cardiac function and attenuates oxidative injury after prolonged myocardial ischemia. , 2004, The Journal of thoracic and cardiovascular surgery.

[10]  Y. Yoshimura,et al.  The intermediary metabolite pyruvate attenuates stunning and reduces infarct size in in vivo porcine myocardium. , 2004, American journal of physiology. Heart and circulatory physiology.

[11]  J. Kellum,et al.  Evidence That Glutathione Depletion Is a Mechanism Responsible for the Anti-Inflammatory Effects of Ethyl Pyruvate in Cultured Lipopolysaccharide-Stimulated RAW 264.7 Cells , 2004, Journal of Pharmacology and Experimental Therapeutics.

[12]  G. Hasenfuss,et al.  Improved systolic and diastolic myocardial function with intracoronary pyruvate in patients with congestive heart failure , 2003, European journal of heart failure.

[13]  R. Mallet,et al.  Pyruvate-enhanced cardioprotection during surgery with cardiopulmonary bypass. , 2003, Journal of cardiothoracic and vascular anesthesia.

[14]  S. Hewitt,et al.  Ethyl pyruvate decreases sepsis-induced acute renal failure and multiple organ damage in aged mice. , 2003, Kidney international.

[15]  M. Fink,et al.  Dose-dependent effects of ethyl pyruvate in mice subjected to mesenteric ischemia and reperfusion , 2003, Intensive Care Medicine.

[16]  J. Vincent,et al.  Low-dose vasopressin in the treatment of septic shock in sheep. , 2003, American journal of respiratory and critical care medicine.

[17]  M. Fink.  Ringer's ethyl pyruvate solution: a novel resuscitation fluid for the treatment of hemorrhagic shock and sepsis. , 2003, The Journal of trauma.

[18]  M. Fink,et al.  Ethyl Pyruvate Ameliorates Intestinal Epithelial Barrier Dysfunction in Endotoxemic Mice and Immunostimulated Caco-2 Enterocytic Monolayers , 2003, Journal of Pharmacology and Experimental Therapeutics.

[19]  J. Kellum,et al.  Resuscitation with Ringer's Ethyl Pyruvate Solution Prolongs Survival and Modulates Plasma Cytokine and Nitrite/Nitrate Concentrations in a Rat Model of Lipopolysaccharide-Induced Shock , 2002, Shock.

[20]  K. Tracey,et al.  Ethyl pyruvate prevents lethality in mice with established lethal sepsis and systemic inflammation , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[21]  M. Fink,et al.  Ethyl pyruvate modulates inflammatory gene expression in mice subjected to hemorrhagic shock. , 2002, American journal of physiology. Gastrointestinal and liver physiology.

[22]  M. Fink,et al.  Resuscitation from Hemorrhagic Shock with Ringer's Ethyl Pyruvate Solution Improves Survival And Ameliorates Intestinal Mucosal Hyperpermeability in Rats , 2002, Shock.

[23]  G. Biagini,et al.  The antioxidant potential of pyruvate in the amitochondriate diplomonads Giardia intestinalis and Hexamita inflata. , 2001, Microbiology.

[24]  Christian Rosenmund,et al.  Identification of Differentiation-Associated Brain-Specific Phosphate Transporter as a Second Vesicular Glutamate Transporter (VGLUT2) , 2001, The Journal of Neuroscience.

[25]  J. Koh,et al.  Protection by Pyruvate against Transient Forebrain Ischemia in Rats , 2001, The Journal of Neuroscience.

[26]  M. Fink,et al.  Ringer’s ethyl pyruvate solution ameliorates ischemia/reperfusion-induced intestinal mucosal injury in rats , 2001, Critical care medicine.

[27]  R. Bünger,et al.  Pyruvate improves cerebral metabolism during hemorrhagic shock. , 2001, American journal of physiology. Heart and circulatory physiology.

[28]  C. Wood,et al.  Sodium pyruvate is better than sodium chloride as a resuscitation solution in a rodent model of profound hemorrhagic shock , 2001 .

[29]  R. Mallet.  Pyruvate: metabolic protector of cardiac performance. , 2000, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[30]  C. Wood,et al.  Sodium pyruvate is better than sodium chloride as a resuscitation solution in a rodent model of profound hemorrhagic shock. , 1999, Resuscitation.

[31]  L. Rochette,et al.  Antioxidative properties of pyruvate and protection of the ischemic rat heart during cardioplegia. , 1999, Journal of cardiovascular pharmacology.

[32]  D. Papanicolaou,et al.  The Pathophysiologic Roles of Interleukin-6 in Human Disease , 1998, Annals of Internal Medicine.

[33]  R. Shenkar,et al.  Hyperoxia activates NF-kappaB and increases TNF-alpha and IFN-gamma gene expression in mouse pulmonary lymphocytes. , 1996, Journal of immunology.

[34]  W. Schraut,et al.  Pyruvate prevents ischemia-reperfusion mucosal injury of rat small intestine. , 1996, American journal of surgery.

[35]  J. Saxe,et al.  Colloid oncotic pressure and body water dynamics in septic and injured patients. , 1991, The Journal of trauma.

[36]  R. Bünger,et al.  Pyruvate-enhanced phosphorylation potential and inotropism in normoxic and postischemic isolated working heart. Near-complete prevention of reperfusion contractile failure. , 1989, European journal of biochemistry.

[37]  H. Schmidt,et al.  Carbon isotope effects on the decarboxylation of carboxylic acids. Comparison of the lactate oxidase reaction and the degradation of pyruvate by H2O2. , 1988, The Biochemical journal.

[38]  Webb Jl,et al.  Metabolic studies on heart mitochondria. II. The inhibitory action of parapyruvate on the tricarboxylic acid cycle. , 1956 .

[39]  C. M. Montgomery,et al.  Metabolic studies on heart mitochondria. II. The inhibitory action of parapyruvate on the tricarboxylic acid cycle. , 1956, The Journal of biological chemistry.

[40]  C. A. Bunton.  Oxidation of α-Diketones and α-Keto-Acids by Hydrogen Peroxide , 1949, Nature.